Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.3 (
collagenase
)
18,340
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A heparin-binding glycoprotein was purified from conditioned medium of cultured rat Schwann cells. The protein,
p200
, which has an apparent molecular mass of approximately 200 kDa, was identified by its ability to bind the cell surface heparan sulfate proteoglycan N-syndecan (syndecan-3) in a membrane overlay assay. Soluble heparin but not chondroitin sulfate inhibited the binding, suggesting the involvement of heparan sulfate chains of proteoglycan in the interaction. Purified
p200
promoted the attachment and spreading of Schwann cells. Adhesion to
p200
was blocked by heparin, suggesting that heparan sulfate proteoglycans are cell surface receptors for
p200
. The tissue distribution of
p200
was determined by immunoblot analysis with anti-
p200
antibodies. Among neonatal rat tissues examined
p200
was detected only in sciatic nerve and, at lower levels, in skeletal muscle.
p200
expression in sciatic nerve was detectable only during the first 2-3 weeks of postnatal development and was not detected in adult rats. Immunofluorescent staining of rat sciatic nerve showed that
p200
was localized in the extracellular matrix surrounding individual Schwann cells-axon units. Two tryptic peptides from
p200
were purified and sequenced. These contained multiple GXX collagen-like repeats. Bacterial
collagenase
digestion of
p200
produced a product with an apparent molecular mass of approximately 90 kDa. These data suggest that Schwann cells secrete an apparently novel collagen-like adhesive protein that interacts with cells through cell surface heparan sulfate proteoglycans.
...
PMID:Schwann cells secrete a novel collagen-like adhesive protein that binds N-syndecan. 866 84
Anti-
p200
pemphigoid is an autoimmune subepidermal blistering disease characterized by autoantibodies to a 200-kDa protein (
p200
) of the dermal-epidermal junction (DEJ).
p200
has been demonstrated to be distinct from all major DEJ autoantigens and is thought to be important for cell-matrix adhesion. This study provides the first biochemical characterization of
p200
. Differential extraction experiments demonstrated that efficient recovery of
p200
from the dermis was strongly dependent on the presence of reducing agents, suggesting that it forms highly insoluble oligomers and/or is extensively cross-linked to other extracellular matrix components by disulfide bonding.
p200
was resistant to digestion with bacterial
collagenase
, whereas this treatment did degrade major collagenous proteins of the dermis, including type I, VI, and VII collagen. This finding firmly established the noncollagenous nature of
p200
. N-Glycosidase F reduced the molecular size of the
p200
autoantigen from 200 to 190 kDa without decreasing its immunoreactivity. In contrast, digestion of
p200
with neuraminidase, O-glycosidase, chondroitinase ABC, and heparitinase I had no effect on its electrophoretic mobility. These data suggest that the
p200
molecule contains N-glycans but lacks O-linked oligosaccharides and chondroitin/heparan sulfate side chains. Two-dimensional gel electrophoresis demonstrated that
p200
is an acidic protein with an isoelectric point of 5.4 to 5.6. Six different
p200
-specific sera recognized an identical protein spot of two-dimensionally separated dermal extracts, confirming that patients with this novel autoimmune disease indeed form a single pathobiochemical entity.
...
PMID:The autoantigen of anti-p200 pemphigoid is an acidic noncollagenous N-linked glycoprotein of the cutaneous basement membrane. 1467 90